Skip to main content
Caplight Logo









RADiCAIT

RADiCAIT

Private
LondonHealthcare & Life Scienceshttps://radicait.com/

Last Round

Pre Seed

Oct 16, 2025

Total Funding Raised

$1.82M

Company Overview

RADiCAIT is a medical technology company that utilizes foundational artificial intelligence to generate synthetic PET images from CT scans, aiming to improve the accessibility and efficiency of diagnostic imaging.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

medical imagingmedical AIradiology AIdiagnostic softwarelung cancer diagnosticsCT scan analysisAI diagnosticsin silico PEThealthcare analyticsclinical decision supportenterprise SaaSmedtechAI-powered radiologycomputational radiologyusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RADiCAIT Comparables

Compare RADiCAIT with similar companies based on industry and business-model similarity.

RADiCAIT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MRIguidance
67%
Darmiyan
66%
Cercare Medical
66%

RADiCAIT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 16, 2025
AcceleratorDec 4, 2024

Key People

Founding team and executive leadership

Regent Lee

Chief Medical and Innovation Officer, Co-Founder

Founding Team

Sina Shahandeh

Co-founder CTO

Founding Team

Seán Walsh

CEO & co-founder

Founding Team

James Fox

Chief Operating Officer

Executive Team

RADiCAIT Investors

Notable investors and investment history

RADiCAIT investors
InvestorRounds
TechstarsPre Seed, Accelerator
Frontline VenturesPre Seed
Gurtin VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2025

    Grew 400% QoQ from 1 to 5 employees.

  • Oct 27, 2025

    Pilot study with UCSF Health for lung cancer diagnostics.

RADiCAIT Filings

Explore SEC and related filing metadata, where available.

RADiCAIT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RADiCAIT's valuation, stock price, and market status.

Is RADiCAIT a public or private company?

RADiCAIT is a private company.

What is the current stock price of RADiCAIT?

RADiCAIT is a private company, so its shares have no public market price. Caplight tracks RADiCAIT's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RADiCAIT worth (valuation)?

Valuation information for RADiCAIT is not publicly available.

Can I buy RADiCAIT stock?

RADiCAIT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RADiCAIT's last funding round?

RADiCAIT's most recent funding round was Pre Seed on October 16, 2025.

Who are the main investors in RADiCAIT?

Key investors in RADiCAIT include Techstars, Frontline Ventures.

Will RADiCAIT IPO soon?

No public IPO plans have been announced for RADiCAIT.

How can I track RADiCAIT secondary market activity?

Caplight tracks bids, offers, and trades in RADiCAIT's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range4
Year Founded2024
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?